--- title: "Abbisko Cayman (2256) stock: news and investor profile" url: "https://aibio.space/companies/abbisko-cayman/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Abbisko Cayman Limited (HKEX: 2256), China. The directory classifies it as Pharmaceuticals: Major." --- 2256 Abbisko Cayman Limited HKEX · China # Abbisko Cayman (2256) news Abbisko Cayman Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 2256, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Abbisko Cayman news We have not published a story on Abbisko Cayman yet. When there is news, it will appear here. ## Abbisko Cayman at a glance - **Ticker**: 2256 - **Listing**: HKEX - **Country**: China ### Related companies - [CSPC Hunan Jingfeng Pharmaceutical Co](https://aibio.space/companies/cspc-hunan-jingfeng-pharmaceutical/) SZSE: 000908 - [Hinova Pharmaceuticals](https://aibio.space/companies/hinova-pharmaceuticals/) SSE: 688302 - [Hainan Haiyao Co.](https://aibio.space/companies/hainan-haiyao/) SZSE: 000566 - [North China Pharmaceutical Company](https://aibio.space/companies/north-china-pharmaceutical/) SSE: 600812 - [Changzhou Qianhong Bio-Pharma Co.](https://aibio.space/companies/changzhou-qianhong-bio-pharma/) SZSE: 002550 - [Apeloa Pharmaceutical Co.](https://aibio.space/companies/apeloa-pharmaceutical/) SZSE: 000739 - [Zhejiang Jiuzhou Pharmaceutical Co.](https://aibio.space/companies/zhejiang-jiuzhou-pharmaceutical/) SSE: 603456 - [Chongqing Pharscin Pharmaceutical Co.](https://aibio.space/companies/chongqing-pharscin-pharmaceutical/) SZSE: 002907 ### Also on HKEX - [Pak Fah Yeow International](https://aibio.space/companies/pak-fah-yeow-international/) 239 - [Kintor Pharmaceutical](https://aibio.space/companies/kintor-pharmaceutical/) 9939 - [China NT Pharma Group Co.](https://aibio.space/companies/china-nt-pharma/) 1011 - [Zhejiang Laifual Drive Co.](https://aibio.space/companies/zhejiang-laifual-drive/) 3952 - [Beijing Luzhu Biotechnology Co.](https://aibio.space/companies/beijing-luzhu-biotechnology/) 2480 - [Shandong Boan Biotechnology Company., Limited.](https://aibio.space/companies/shandong-boan-biotechnology/) 6955 ## Questions about Abbisko Cayman What is the ticker symbol of Abbisko Cayman? Abbisko Cayman Limited trades under the ticker 2256 on HKEX. Where is Abbisko Cayman listed? Abbisko Cayman Limited is listed on HKEX. Our directory also records these other listings: LSX:A3C4Y0. Which country or territory is Abbisko Cayman listed under? Our directory records Abbisko Cayman Limited under China. What does Abbisko Cayman do? Our directory classifies Abbisko Cayman Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Abbisko Cayman? The ISIN recorded for Abbisko Cayman Limited is KYG0028A1085. Does aibio.space cover Abbisko Cayman? aibio.space lists Abbisko Cayman Limited among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Abbisko Cayman? Companies in our directory listed in the same country and business area as Abbisko Cayman: CSPC Hunan Jingfeng Pharmaceutical Co, Hinova Pharmaceuticals, Hainan Haiyao Co., North China Pharmaceutical Company, Changzhou Qianhong Bio-Pharma Co., Apeloa Pharmaceutical Co.. ## Investor discussion: Abbisko Cayman Members talk about Abbisko Cayman (2256). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Abbisko Cayman, newest first. Each line links the filing it comes from. 1. 2026-04-28 Financings Share or debt issue: COMPLETION OF PLACING OF NEW SHARES UNDER THE GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042803723.pdf) 2. 2026-04-21 Financings Share or debt issue: PLACING OF NEW SHARES UNDER THE GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100107.pdf) 3. 2025-08-28 Mergers Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION - SUBSCRIPTIONS OF WEALTH MANAGEMENT PRODUCTS. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0828/2025082802934.pdf) ## Press releases Headlines of Abbisko Cayman's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-21 HKEXnews [VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS' LAVENGRATINIB (ABSK061) FOR THE TREATMENT OF ACHONDROPLASIA GRANTED ORPHAN DESIGNATION BY EMA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1021/2026102100179.pdf) 2. 2026-09-21 HKEXnews [VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS ANNOUNCES POSITIVE PRELIMINARY PHASE II RESULTS WITH LAVENGRATINIB (ABSK061) FOR THE TREATMENT OF ACHONDROPLASIA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0921/2026092100183.pdf) 3. 2026-09-17 HKEXnews [POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON SEPTEMBER 17, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0917/2026091701695.pdf) 4. 2026-08-31 HKEXnews [VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS COMPLETES FIRST PATIENT DOSING IN PHASE I CLINICAL TRIAL OF NOVEL PAN-KRAS INHIBITOR ABSK211](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0831/2026083100253.pdf) 5. 2026-08-28 HKEXnews [NOTICE OF EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0828/2026082800461.pdf) 6. 2026-08-28 HKEXnews [PROPOSED CHANGE OF COMPANY NAME AND NOTICE OF EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0828/2026082800443.pdf) 7. 2026-08-24 HKEXnews [PROPOSED CHANGE OF COMPANY NAME](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0824/2026082401567.pdf) 8. 2026-08-24 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0824/2026082401541.pdf) 9. 2026-08-19 HKEXnews [VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS ANNOUNCES IND CLEARANCE FROM THE NMPA FOR ORAL SMALL MOLECULE PAN-KRAS INHIBITOR ABSK211](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0819/2026081900225.pdf) 10. 2026-07-13 HKEXnews [VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS ANNOUNCES IND CLEARANCE FROM THE FDA FOR ORAL SMALL MOLECULE PAN-KRAS INHIBITOR ABSK211](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0713/2026071300019.pdf) 11. 2026-07-02 HKEXnews [VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS AND ASTRAZENECA ENTER A STRATEGIC COLLABORATION TO CONDUCT THE CLINICAL TRIAL OF LUMIPODLIN (ABSK043), A FIRST-IN-CLASS ORAL PD-L1 INHIBITOR, IN COMBINATION WITH TAGRISSO FOR NSCLC](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0702/2026070200079.pdf) 12. 2026-06-26 HKEXnews [VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS REPORTS PHASE II DATA OF ABSK061 IN COMBINATION WITH ABSK043 IN FGFR2-POSITIVE ADVANCED GC/GEJC PRESENTED AT 2026 ASCO](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0626/2026062600299.pdf) 13. 2026-06-24 HKEXnews [VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS DEEPENS R&D COLLABORATION WITH LILLY](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0624/2026062400051.pdf) 14. 2026-06-04 HKEXnews [VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS PRESENTS A NOVEL JOINT MODELING FRAMEWORK FOR ABSK-011 (IRPAGRATINIB) IN HCC PATIENTS AT THE PAGE MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0604/2026060400140.pdf) 15. 2026-05-20 HKEXnews [ELEVENTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0520/2026052001336.pdf) 16. 2026-05-20 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 20, 2026 AND AMENDMENTS TO THE ARTICLES](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0520/2026052001326.pdf) 17. 2026-04-28 HKEXnews [COMPLETION OF PLACING OF NEW SHARES UNDER THE GENERAL MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042803723.pdf) 18. 2026-04-28 HKEXnews [Notification Letter and Reply Form to Non-registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042803711.pdf) 19. 2026-04-28 HKEXnews [Notification Letter and Reply Form to Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042803701.pdf) 20. 2026-04-28 HKEXnews [NOTICE OF THE ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042803629.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:2256 on TradingView](https://www.tradingview.com/symbols/HKEX-2256/). ## Listing details Abbisko Cayman Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 2256, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Abbisko Cayman Limited - **Ticker**: 2256 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Pharmaceuticals: Major - **ISIN**: KYG0028A1085 - **Other listed symbols**: LSX:A3C4Y0 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-2256/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/abbisko-cayman/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Abbisko Cayman (2256) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/abbisko-cayman/